Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study

by Benedetti, F., Ceresoli, G.L, Dagher, J., Froesch, P., Früh, M., Grosso, F., Hayoz, S., Kandalaft, L., Maconi, A., Mark, M., Metaxas, Y., Pless, M., Rusakiewicz, S., Schmid, S., Schneider, M., Tarussio, D., Tissot-Renaud, S., von Moos, R., Zucali, P.
Published 2022

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

by Andreatta, M., Barras, D., Benedetti, F., Berthold, D.R, Bourhis, J., Carmona, S.J, Corria-Osorio, J., Coukos, G., Crespo, I., Dafni, U., de Olza, M.O, Dimopoulou, G., Dromain, C., Duran, R., Foukas, P., Genolet, R., Ghisoni, E., Harari, A., Herrera, F.G, Imbimbo, M., Irving, M., Kandalaft, L.E, Laniti, D.D, Messemaker, M., Orcurto, A., Pittet, M.J, Prior, J., Rodrigo, B.N, Ronet, C., Rusakiewicz, S., Sarivalasis, A., Schaefer, N., Sempoux, C., Smith, T., Spill, A., Tsourti, Z., Warren, S.E, Zaman, K., Zimmermann, S.
Published 2022